Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet ImmunologyEmily Sirotich, Gordon Guyatt, Caroline Gabe, et al.
Haematologica|September 28, 2019
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT StudyFrancesco Paciullo, Loredana Bury, Patrizia Noris, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
Thrombosis and Haemostasis|February 5, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Thrombosis and Haemostasis|November 27, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Nature Reviews. Cardiology|March 21, 2024
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseAzita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, et al.
Blood Advances|April 9, 2025
Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicenter Cohort StudyEmily Sirotich, Saifur R Chowdhury, Dimpy Modi, et al.
Blood Advances|June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet ImmunologyEmily Sirotich, Gordon Guyatt, Caroline Gabe, et al.
Haematologica|September 28, 2019
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT StudyFrancesco Paciullo, Loredana Bury, Patrizia Noris, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
Thrombosis and Haemostasis|February 5, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Thrombosis and Haemostasis|November 27, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Nature Reviews. Cardiology|March 21, 2024
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseAzita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, et al.
Blood Advances|April 9, 2025
Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicenter Cohort StudyEmily Sirotich, Saifur R Chowdhury, Dimpy Modi, et al.
Blood Advances|June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Pageof 26